Audiometry-measured hearing loss in older adults accounted for up to 32% of incident dementia cases over 8 years in new research, significantly larger than previously reported estimates. Investigators ...
Zacks Investment Research on MSN
REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.
The Audiology group in the UAB Department of Otolaryngology includes three main components: diagnostic testing, hearing aid services, and cochlear implants. Pure tone and speech audiometry Impedance ...
MedPage Today on MSN
Gene Therapy Restores Hearing for Rare Cause of Congenital Deafness
A novel gene therapy enabled children with congenital deafness due to otoferlin (OTOF) gene variants to hear for the first ...
Genetic deficiency of otoferlin, a protein critical to synaptic transmission by the sensory hair cells of the ear, causes congenital deafness. Medicines to treat the condition are lacking; ...
The drugmaker said it plans to submit a regulatory application for DB-OTO to the FDA later this year, pending discussions with the agency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback